ClinicalTrials.gg
Sign In

Growth Disorders clinical trials

The registry lists 227 studies for Growth Disorders across more than 10 countries. 25 are recruiting or about to start. 134 of them are mainly about Growth Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its narrower condition Fetal Growth Retardation too: 487 studies, 94 open.

Get an email when these change. Save the Growth Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
151
Status unknown
26
Recruiting
18
Active, not recruiting
13
Terminated
7
Not yet recruiting
7

Phase

Phase 3
25
Phase 2
17
Phase 1
6
Phase 4
1

Where

United States
25
Indonesia
18
Pakistan
18
Bangladesh
18
United Kingdom
9
France
9

Who runs them

Merck KGaA, Darmstadt, Germany (20) · Aga Khan University (12) · Washington University School of Medicine (9) · Johns Hopkins Bloomberg School of Public Health (9) · Novo Nordisk A/S (8) · International Centre for Diarrhoeal Disease Research, Bangladesh (6) · Tampere University (4) · Assiut University (4)

What is being tested here

Drugs under test in Growth Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Human Growth Hormone159
Nesiritide101
Somavaratan033
Azithromycin023
Mecasermin033
Moringa002
Egg as food012
Pasireotide012
VE818001
Streptococcus thermophilus001

Coming up

4phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 18 Growth Disorders studies recruiting now, 3 (17%) set no upper age limit and 13 (72%) stop at 75 or younger. 16 (89%) take children under 18. 4 (22%) are for women only and 0 (0%) for men only; 9 (50%) take healthy volunteers.

Recruiting studies that take each age, of 18
AgeWomenMen
108 (44%)7 (39%)
1810 (56%)6 (33%)
307 (39%)4 (22%)
407 (39%)4 (22%)
505 (28%)4 (22%)
655 (28%)4 (22%)
755 (28%)4 (22%)
855 (28%)4 (22%)

Across all 227 studies, recruiting or not: 79% stop at 75 or younger and 79% at 65; 89% take children; 13% are for women only and 1% for men only; 53% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Growth Disorders studies take

Of 78 interventional studies with no phase under Growth Disorders, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase23 mo12–30 · 78 studies—23 mo12–30 · 77 studies
Observational43 mo21–55 · 42 studies45 mo30–55 · 23 studies—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 227. Browse all 227 → or search them.